BofA Securities maintains Novartis at Buy
Wednesday, 29 March 2023, 03:36:35
https://www.investing.com/news/pro/novartis-receives-investment-bank-analyst-rating-update-3043349
— Investing.com
Novartis Puts Up $50M to Steer Bicycle Therapeutics’ Tech Into New Cancer Meds – MedCity News
Wednesday, 29 March 2023, 01:26:35
Novartis is partnering with Bicycle Therapeutics to see if the biotech’s technology can be used to develop better, more targeted radiopharmaceuticals. The deal covers two targets that were not disclosed.
— MedCity News
Bicycle Therapeutics In Deal With Novartis To Develop Bicycle Radio-conjugates
Tuesday, 28 March 2023, 15:10:18
… into a partnership with Swiss Pharma major Novartis AG to develop, and … oncology targets. Bicycle Therapeutics develops drugs based on its proprietary bicyclic … Bicycle-based medicines commercialized by Novartis . “This collaboration builds on …
— EIN News Pharmaceuticals
Health Care Roundup: Market Talk
Tuesday, 28 March 2023, 14:17:00
Find insight on Evotec, Novartis and more in the latest Market Talks covering the Health Care sector.
— The Wall Street Journal
Bicycle stock pops on cancer drug discovery pact with Novartis, gets $50M upfront
Tuesday, 28 March 2023, 13:27:49
Bicycle Therapeutics (BCYC) signed an agreement with Novartis (NVS) to develop and sell radio-conjugates for oncology targets. Read more here
— Seeking Alpha
We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.
